Samchem India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 04-11-2024
- Paid Up Capital ₹ 0.10 M
as on 04-11-2024
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.60 Cr
as on 04-11-2024
- Revenue -8.90%
(FY 2023)
- Profit -41.62%
(FY 2023)
- Ebitda -29.51%
(FY 2023)
- Net Worth 51.58%
(FY 2023)
- Total Assets 2.63%
(FY 2023)
About Samchem India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.60 Cr.
Gulshan Khurana and Varun Khurana serve as directors at the Company.
- CIN/LLPIN
U52311DL2020PTC369608
- Company No.
369608
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Sep 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Samchem India Private Limited offer?
Samchem India Private Limited offers a wide range of products and services, including Antibiotic Injection, Meropenem Injection, Diabetes Medicine, Metformin Tablets, API Intermediate, Cardiovascular Drugs & Medication, Anticoagulant and Antiplatelet Drugs, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Blood Pressure Medicine.
Who are the key members and board of directors at Samchem India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gulshan Khurana  | Director | 09-Sep-2020 | Current |
| Varun Khurana | Director | 09-Sep-2020 | Current |
Financial Performance of Samchem India.
Samchem India Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.9% decrease. The company also saw a substantial fall in profitability, with a 41.62% decrease in profit. The company's net worth Soared by an impressive increase of 51.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Samchem India?
Unlock access to Samchem India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 02 Nov 2022 | ₹1.00 Cr | Open |
Axis Bank Limited Creation Date: 13 Apr 2022 | ₹6.00 M | Open |
How Many Employees Work at Samchem India?
Samchem India has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Samchem India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Samchem India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
